J. C. Tonn

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia et al. · The Lancet Oncology · 2014 · 1K citations

Medicine, Oncology, Pharmacotherapy +14

Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

Riccardo Soffietti, Ufuk Abacıoğlu, Brigitta G. Baumert et al. · Neuro-Oncology · 2016 · 503 citations · Full text

Medicine, Oncology, Surgery +17

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah et al. · Neuro-Oncology · 2019 · 274 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas

Mathias Kunz, Niklas Thon, Sabina Eigenbrod et al. · Neuro-Oncology · 2011 · 245 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy

Friedrich-Wilhelm Kreth, Niklas Thon, Matthias Simon et al. · Annals of Oncology · 2013 · 207 citations · Full text

Medicine, Oncology, Surgery +15